Clinical trial
Safety and Tolerability of Deferoxamine in Acute Cerebral Hemorrhage
NCT00598572 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Tolerability of Deferoxamine in Acute Cerebral Hemorrhage
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- April 30, 2010
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intracerebral hemorrhage